Liberty Biopharma (CVE:LTY) Share Price Crosses Below 200 Day Moving Average – What’s Next?

by · The Markets Daily

Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s share price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares trading hands.

Liberty Biopharma Stock Up ∞

The firm has a 50 day moving average of C$2.00 and a 200 day moving average of C$2.00. The firm has a market cap of C$21.54 million and a price-to-earnings ratio of -12.66. The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 8.19.

Liberty Biopharma Company Profile

(Get Free Report)

Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.

Further Reading